At Phenomena Pharma, our vision has always been clear: to contribute meaningfully to improving healthcare by delivering innovative, safe, and effective pharmaceutical solutions. Since the founding of the company, we have believed that medicine is not only a business but also a responsibility toward patients, healthcare professionals, and society as a whole.

Egypt has long been a center of medical excellence in the region, and our mission is to strengthen that position by introducing high-quality pharmaceutical products that meet international standards. Through continuous research, strategic partnerships, and a commitment to scientific integrity, Phenomena Pharma aims to bring advanced therapies to the Egyptian market.

Our portfolio — including products such as Vonanavy (Vonoprazan), Naplema (Rosuvastatin), and Glempozin (Empagliflozin) — reflects our dedication to addressing critical therapeutic areas and improving patient outcomes. Each product is developed and delivered with strict adherence to quality, safety, and regulatory compliance.

However, our success is not measured solely by the medicines we provide. It is measured by the trust we build with physicians, pharmacists, healthcare institutions, and patients. We are committed to maintaining transparency, ethical standards, and long-term partnerships within the healthcare community.

As we look to the future, Phenomena Pharma will continue investing in innovation, expanding our therapeutic portfolio, and supporting the advancement of healthcare in Egypt and beyond.

I would like to thank our dedicated team, our partners, and the healthcare professionals who trust our products and share our mission of improving lives.

Together, we move healthcare forward.